The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

KCNH1  -  potassium channel, voltage gated eag...

Homo sapiens

Synonyms: EAG, EAG channel 1, EAG1, Ether-a-go-go potassium channel 1, Kv10.1, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of KCNH1


High impact information on KCNH1

  • Heteromultimeric interactions among K+ channel subunits from Shaker and eag families in Xenopus oocytes [6].
  • Inhibition of EAG expression in several of these cancer cell lines causes a significant reduction of cell proliferation [7].
  • We have investigated the possible implication of the cell cycle-regulated K(+) channel ether à go-go (EAG) in cell proliferation and transformation [7].
  • We show that transfection of EAG into mammalian cells confers a transformed phenotype [7].
  • Advances made in cloning K+ channel subunits of the Kv, eag, Kir, and IsK families are discussed, and progress made in identifying the K+ channel subunits expressed in the mammalian myocardium is summarized [8].

Biological context of KCNH1

  • In the electrophysiological study, NPMM-differentiated hMSCs expressed two delayed rectifier K(+) currents related to two ether-??-go-go K(+) channels (eag1, eag2), which are fundamental for setting the negative resting potentials required for neuronal survival and basal cell activity [9].
  • Immunochemistry experiments showed the presence of EAG channel protein in cells from the primary cultures and in cervical cancer biopsies sections from the same patients [1].
  • The h-eag gene was localized to chromosome 1q32-41, and is expressed as a approximately 9 kb transcript in myogenic cells and in adult brain tissue [10].
  • 3. h-eag shows a marked Cole-Moore shift, i.e. the activation kinetics become very slow when the depolarization starts from a very negative holding potential [4].
  • 5. When cells were grown in the presence of 10 microM retinoic acid in order to synchronize the cell line in the G1 phase of the cell cycle, h-eag current was reduced to less than 5 % of the control value, while the delayed rectifier channel was expressed more abundantly [4].

Anatomical context of KCNH1

  • Upon expression in mammalian cells and Xenopus laevis oocytes, we investigated the inhibition of the closely related hEAG1 and hEAG2 channels by agents that have previously been reported to block hERG1 channels [11].
  • Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K(+) channel types [9].
  • In addition, human EAG mRNA is detected in several somatic cancer cell lines, despite being preferentially expressed in brain among normal tissues [7].
  • In normal tissues, EAG mRNA is almost exclusively expressed in brain, but it is expressed in several somatic cancer cell lines, including HeLa, from cervix [1].
  • We have isolated the full-length coding region of a human ether-a-go-go K+ channel (h-eag) from myoblasts undergoing differentiation [10].

Associations of KCNH1 with chemical compounds

  • A modeling approach that allowed for partial conformational relaxation of hEAG model structures upon ligand docking suggests that high-affinity block of ether à go-go channels is mediated by an anchoring of the clofilium alkane tail between S6 and the pore helices [11].
  • Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels [12].
  • 6. Acute application of 10 microM retinoic acid blocked the delayed rectifier channel but enhanced the h-eag current [4].
  • Selective deletion of the HERG-specific sequence (HERG Delta138-373) located between the conserved initial amino terminus (the eag or PAS domain) and the first transmembrane helix accelerates channel activation and shifts its voltage dependence to hyperpolarized values [13].
  • 3 The block of hEAG1 channels by LY97241 and clofilium was time-, use-, and voltage-dependent, best explained by an open-channel block mechanism [14].

Other interactions of KCNH1

  • In this study, we used chimeras constructed from hERG and ether-a'-go-go (EAG) channels to identify interactions between residues in the S4-S5 linker and S6 domain that were critical for stabilizing the channel in a closed state [15].
  • However, its voltage dependence was smaller and, therefore, hEAG2 channels start to open at more negative voltages than hEAG1 [16].
  • KCR1 also accelerates the activation of rat EAG K+ channels expressed in Xenopus oocytes or in COS-7 cells [17].
  • The technique is demonstrated here using the human ether-a-go-go potassium channel and the kinase SRC [18].

Analytical, diagnostic and therapeutic context of KCNH1

  • Reverse transcription-PCR and Southern-blot experiments revealed eag expression in 100% of the cancerous samples and in 33% of the normal biopsies [1].
  • Far-Western blotting revealed that KCR1 and EAG proteins interacted with each other by means of their C-terminal regions [17].
  • Site-directed mutagenesis indicates that the eag carboxyl terminus is crucial for this interaction, exerting effects preferentially on N-type inactivation [6].
  • The suppressive factor as well as the capacity to restore EAG rosette formation by modulated lymphocytes were destroyed by heating (56 degrees C, 30 min) or by freezing and thawing [19].
  • This study reports a multicenter EAG repair versus COS repair parallel cohort trial at 12 months and additional observations of specific device failure types and their impact on an aortic endograft design beyond that follow-up period [5].


  1. Ether a go-go potassium channels as human cervical cancer markers. Farias, L.M., Ocaña, D.B., Díaz, L., Larrea, F., Avila-Chávez, E., Cadena, A., Hinojosa, L.M., Lara, G., Villanueva, L.A., Vargas, C., Hernández-Gallegos, E., Camacho-Arroyo, I., Dueñas-González, A., Pérez-Cárdenas, E., Pardo, L.A., Morales, A., Taja-Chayeb, L., Escamilla, J., Sánchez-Peña, C., Camacho, J. Cancer Res. (2004) [Pubmed]
  2. Expression of ether à go-go potassium channels in human gliomas. Patt, S., Preussat, K., Beetz, C., Kraft, R., Schrey, M., Kalff, R., Schönherr, K., Heinemann, S.H. Neurosci. Lett. (2004) [Pubmed]
  3. Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells. Smith, G.A., Tsui, H.W., Newell, E.W., Jiang, X., Zhu, X.P., Tsui, F.W., Schlichter, L.C. J. Biol. Chem. (2002) [Pubmed]
  4. Characterization of an eag-like potassium channel in human neuroblastoma cells. Meyer, R., Heinemann, S.H. J. Physiol. (Lond.) (1998) [Pubmed]
  5. Results of an aortic endograft trial: impact of device failure beyond 12 months. Beebe, H.G., Cronenwett, J.L., Katzen, B.T., Brewster, D.C., Green, R.M. J. Vasc. Surg. (2001) [Pubmed]
  6. Heteromultimeric interactions among K+ channel subunits from Shaker and eag families in Xenopus oocytes. Chen, M.L., Hoshi, T., Wu, C.F. Neuron (1996) [Pubmed]
  7. Oncogenic potential of EAG K(+) channels. Pardo, L.A., del Camino, D., Sánchez, A., Alves, F., Brüggemann, A., Beckh, S., Stühmer, W. EMBO J. (1999) [Pubmed]
  8. Myocardial potassium channels: electrophysiological and molecular diversity. Barry, D.M., Nerbonne, J.M. Annu. Rev. Physiol. (1996) [Pubmed]
  9. Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K(+) channel types. Mareschi, K., Novara, M., Rustichelli, D., Ferrero, I., Guido, D., Carbone, E., Medico, E., Madon, E., Vercelli, A., Fagioli, F. Exp. Hematol. (2006) [Pubmed]
  10. Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. Occhiodoro, T., Bernheim, L., Liu, J.H., Bijlenga, P., Sinnreich, M., Bader, C.R., Fischer-Lougheed, J. FEBS Lett. (1998) [Pubmed]
  11. Molecular determinants for high-affinity block of human EAG potassium channels by antiarrhythmic agents. Gessner, G., Zacharias, M., Bechstedt, S., Schönherr, R., Heinemann, S.H. Mol. Pharmacol. (2004) [Pubmed]
  12. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels. Ficker, E., Jarolimek, W., Brown, A.M. Mol. Pharmacol. (2001) [Pubmed]
  13. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating. Viloria, C.G., Barros, F., Giráldez, T., Gómez-Varela, D., de la Peña, P. Biophys. J. (2000) [Pubmed]
  14. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241. Gessner, G., Heinemann, S.H. Br. J. Pharmacol. (2003) [Pubmed]
  15. The S4-S5 Linker Directly Couples Voltage Sensor Movement to the Activation Gate in the Human Ether-a-go-go-related Gene (hERG) K+ Channel. Ferrer, T., Rupp, J., Piper, D.R., Tristani-Firouzi, M. J. Biol. Chem. (2006) [Pubmed]
  16. Functional distinction of human EAG1 and EAG2 potassium channels. Schönherr, R., Gessner, G., Löber, K., Heinemann, S.H. FEBS Lett. (2002) [Pubmed]
  17. KCR1, a membrane protein that facilitates functional expression of non-inactivating K+ currents associates with rat EAG voltage-dependent K+ channels. Hoshi, N., Takahashi, H., Shahidullah, M., Yokoyama, S., Higashida, H. J. Biol. Chem. (1998) [Pubmed]
  18. Fast small molecule similarity searching with multiple alignment profiles of molecules represented in one-dimension. Wang, N., DeLisle, R.K., Diller, D.J. J. Med. Chem. (2005) [Pubmed]
  19. Suppression of the late stages of mitogen-induced human B cell differentiation by FC gamma receptors (FC gamma R) released from polymorphonuclear neutrophils. Bich-Thuy, L.T., Samarut, C., Brochier, J., Revillard, J.P. J. Immunol. (1981) [Pubmed]
WikiGenes - Universities